Skip to search.
 TSX Up 0.60% TSX Ventures Up 1.02%

Nektar Therapeutics (NKTR)

-NasdaqGS
12.61 Up 0.28(2.27%) Jul 31, 4:00PM EDT
|After Hours : 12.28 Down 0.33 (2.60%) Jul 31, 5:36PM EDT
Add to Portfolio
Prev Close:12.33
Open:12.35
Bid:11.01 x 100
Ask:14.80 x 100
1y Target Est:16.25
Beta:0.95
Next Earnings Date: 5-Aug-15NKTR Earnings announcement
Day's Range:12.19 - 12.83
52wk Range:9.51 - 17.53
Volume:915,760
Avg Vol (3m):1,767,160
Market Cap:1.66B
P/E (ttm):63.69
EPS (ttm):0.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
NKTRUp 2.27%1.66B
BMYUp 1.83%109.45B
ENZNDown 0.72%60.53M
GSKDown 0.34%104.91B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.54
Quarterly EPS Est (Jun-15) :-0.40
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):3.13

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nektar Therapeutics, a biopharmaceutical company, develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback